Clinical Trials
24 trialsNCT03756311 2026-01-23
Expanded Access to NanoPac
NanOlogy, LLC
No longer available
NCT03523338 2025-12-10
An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate Cancer
Aragon Pharmaceuticals, Inc.
No longer available
NCT05064306 2025-08-01
131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults
Memorial Sloan Kettering Cancer Center
No longer available
NCT05941637 2024-12-31
An Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF)
Lynkcell Europe
No longer available
NCT03874455 2024-03-22
Tazemetostat Expanded Access Program for Adults With Solid Tumors
Ipsen
No longer available
NCT05002465 2023-09-11
Clinical Use of 68Ga PSMA-11 PET/CT in Diagnosing, Staging and Restaging Prostate Cancer
University of Texas Southwestern Medical Center
No longer available
NCT05415228 2023-05-18
Expanded Access to Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrent Prostate Cancer
University of Michigan
No longer available
NCT04854369 2023-04-11
Firefly
Tulane University
No longer available
NCT04825652 2023-01-13
177Lu-PSMA-617 Managed Access Program for mCRPC Patients
Advanced Accelerator Applications
No longer available
NCT03501940 2022-01-21
F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer
Stanford University
No longer available
NCT04800068 2022-01-21
Expanded Access [Ga-68] PSMA-11 PET Imaging
Mayo Clinic
No longer available
NCT03801278 2021-12-13
FPA144
Five Prime Therapeutics, Inc.
No longer available
NCT02826395 2020-07-24
C11 Sodium Acetate PET/CT Imaging of PCa
Jonsson Comprehensive Cancer Center
No longer available
NCT02531672 2020-06-05
Detecting Recurrent Prostate Cancer With 11C-choline Positron Emission Tomography
Memorial Sloan Kettering Cancer Center
No longer available
NCT03554434 2020-03-02
An Expanded Access Program for AM0010 (Pegilodecakin)
Eli Lilly and Company
No longer available
NCT03386071 2019-01-16
Compassionate Use: Progressive Metastatic Castrate Resistant Prostate Cancer; Monotherapy Treatment With Trametinib
Jonsson Comprehensive Cancer Center
No longer available
NCT01834209 2018-11-07
A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate Cancer
Janssen Research & Development, LLC
No longer available
NCT01777061 2018-05-16
Clinical Management Decisions for Recurrent Prostate Cancer Patients Based on [11C]Acetate PET Scan
University of Kansas Medical Center
No longer available
NCT03005262 2018-04-04
MLN8237 for a Subject With Adenocarcinoma of the Prostate
The University of Texas Health Science Center at San Antonio
No longer available
NCT01956253 2017-03-14
Single Subject Neratinib in Bladder Cancer (NRR)
UNC Lineberger Comprehensive Cancer Center
No longer available
NCT01516762 2014-07-14
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Bayer
No longer available
NCT01473043 2014-05-30
Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line Treatment
Pfizer
No longer available
NCT00655252 2011-08-19
Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy
Novartis
No longer available
NCT00636259 2008-06-11
Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer
AstraZeneca
No longer available